| Budget Amount *help |
¥4,810,000 (Direct Cost: ¥3,700,000、Indirect Cost: ¥1,110,000)
Fiscal Year 2017: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2016: ¥1,300,000 (Direct Cost: ¥1,000,000、Indirect Cost: ¥300,000)
Fiscal Year 2015: ¥2,210,000 (Direct Cost: ¥1,700,000、Indirect Cost: ¥510,000)
|
|---|
| Outline of Final Research Achievements |
Fisher syndrome (FS) is a regional variant of Guillain-Barre syndrome, in which molecular mimicry between antecedent infectious agents and host tissue is a highly attractive explanation for the pathogenesis. Campylobacter jejuni is recognized as the agent that most frequently triggers FS and Haemophilus influenzae is as the second antecedent agent. The clinical, serological and cerebrospinal fluid data of patients with H. influenzae-associated FS were analyzed and compared to these of patients with C. jejuni-associated FS. Although there were some differences of clinical profiles between patients with H. influenzae- and C. jejuni-associated FS, autoantibody patterns (antigen specificities and IgG subclasses) and findings of cerebrospinal fluid were similar to the both groups. Concentration of serum membrane-attack complex did not differ between the groups. These findings suggest the common pathogenesis of H. influenzae-associated FS with C. jejuni-associated FS.
|
